Recruiting A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas NCT07217171 Conditions Anal Squamous Cell Carcinoma, Anus Diseases, Anus Neoplasms, +38 more Locations City of Hope — Duarte, California, United States USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States Yale University Cancer Center — New Haven, Connecticut, United States The Winship Cancer Institute Emory University — Atlanta, Georgia, United States View more locations Show fewer locations Loading locations... View Trial Details
Recruiting Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors NCT04429542 Conditions Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +39 more Locations Moores Cancer Center UC San Diego Health — La Jolla, California, United States Keck School of Medicine of USC — Los Angeles, California, United States UCLA — Los Angeles, California, United States University of California, Davis Comprehensive Cancer Center — Sacramento, California, United States View all 20 locations View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors NCT05120271 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +28 more Locations Hoag Hospital Newport Beach — Newport Beach, California, United States Baylor Scott and White Research Institute — Dallas, Texas, United States University of Texas MD Anderson Cancer Center — Houston, Texas, United States Fred Hutchinson Cancer Center - Seattle Cancer Care Alliance (SCCA) Location — Seattle, Washington, United States View more locations Show fewer locations Loading locations... View Trial Details
